Therapy of bipolar affective illnesses
with valproate. A review of the literature
by
Retzow A, Emrich HM
Psychiatr Prax 1998 Jul; 25(4):163-71

ABSTRACT

This paper gives an overall review of the literature since 1980 on the use of valproate in bipolar affective disorders. Randomised comparative studies definitely demonstrate that valproate proves superior in comparison with placebo and equivalent in comparison with lithium in the treatment of acute manic episodes. A series of open studies indicates a reduction in frequency and intensity of manic and depressive episodes with the long-term administration of valproate suggesting efficaciousness in the prophylaxis of bipolar affective disorders. Details on dosage, side effects and potential interactions with this group of patients are presented. Valproate constitutes a further valuable and well tolerated alternative to lithium, antipsychotic agents and carbamazepine not only in acute therapy of manic episodes but also in prophylactic treatment of patients with bipolar psychosis.

Mania
Lithium
Options
Valproate
Gabapentin
Lamotrigine
Carbamazepine
Bipolar disorders
Bipolar depression
Dysphoric hypomania
Bipolar polypharmacy
Valproate for bipolars
Bipolar versus unipolar
Lithium versus carbamazepine
Valproic acid, valproate and divalproex
Valproate used to treat acute mood episodes
Long-lasting effects of prenatal exposure to valproic acid
Olanzapine-fluoxetine combination (Symbyax) for depression

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family